Market Access News | pharmaphorum

News

syringe being filled by hand with vaccine

UK orders 5 million bird flu jabs for pandemic preparedness

The UKHSA has taken steps to prepare for a possible bird flu outbreak by placing an order with Seqirus for millions of H5 vaccine doses.

News

MHRA's stature undermined by lack of resources says pharma

The MHRA isn't sufficiently funded to meet its obligations and that could threaten UK investment in life sciences, according to an ABPI report.

News

Warning letter adds to Applied Tx run of bad news

Applied Therapeutics gets a warning letter from the FDA over a trial of rare disease drug govorestat, which was rejected by the agency last week.

News

Cytokinetics' president and chief executive Robert Blum

FDA kicks off review of Cytokinetics' aficamten for HCM

Cytokinetics should hear back from the FDA next September about its application for Camzyos rival aficamten in obstructive hypertrophic cardiomyopathy

News

'UK Only' red stamp on manufacturing facility

Deadline looms for post-Brexit label changes for UK meds

The MHRA has reminded pharma companies that from 1st January all medicines sold in the UK will have to comply with new labelling requirements.

News

BMS files legal challenge to HHS' 340B rebate decision

Bristol-Myers Squibb has become the latest pharma in the US to file a legal challenge to a block on a 340B drug rebate model opposed by HRSA.

UK orders 5 million bird flu jabs for pandemic preparedness

MHRA's stature undermined by lack of resources says pharma

Warning letter adds to Applied Tx run of bad news

FDA kicks off review of Cytokinetics' aficamten for HCM

Deadline looms for post-Brexit label changes for UK meds

BMS files legal challenge to HHS' 340B rebate decision

Dexcom is first to join FDA/CMS health tech pilot

Discover a new era of healthcare panel engagement: Grounded ...

News

Editor's Picks